Author:
Tang Hung-Jen,Lin Hsin-Lan,Lin Yu-Hsiu,Leung Pak-On,Chuang Yin-Ching,Lai Chih-Cheng
Publisher
Springer Science and Business Media LLC
Reference23 articles.
1. Centers for Disease Control and Prevention (CDC): Vital signs: central line-associated bloodstream infection – United States, 2001, 2008, and 2009. MMWR Morb Mortal Wkly Rep. 2011, 60: 243-248.
2. Fagan RP, Edwards JR, Park BJ, Fridkin SK, Magill SS: Incidence trends in pathogen-specific central line-associated bloodstream infections in US intensive care units. Infect Control Hosp Epidemiol. 2013, 36: 893-899.
3. Boyce JM: Prevention of central line-associated bloodstream infections in hemodialysis patients. Infect Control Hosp Epidemiol. 2012, 33: 936-944.
4. Rosenthal VD: Central line-associated bloodstream infections in limited-resource countries: a review of the literature. Clin Infect Dis. 2009, 49: 1899-1907.
5. Rosenthal VD, Guzman S, Migone O, Crnich CJ: The attributable cost length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care department in Argentina: a prospective, matched analysis. Am J Infect Control. 2003, 34: 475-480.
Cited by
54 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献